Year Founded
1992
Ownership
Public
Employees
~13958
Stage
Commercial
Modalities
OtherSmall molecule

Yiling Pharmaceutical General Information

Leading Chinese pharmaceutical company focused on Traditional Chinese Medicine (TCM) with significant growth in 2020. Key product Lianhua Qingwen showed clinical efficacy in COVID-19 treatment.

Contact Information

Website
Primary Industry
Pharma
Corporate Office
Shijiazhuang,
China

Drug Pipeline

Lianhua Qingwen
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Yiling Pharmaceutical's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Yiling Pharmaceutical Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Yiling Pharmaceutical's complete valuation and funding history, request access »